Original Release Date: 4/20/2017
Review Date: 2/28/2020, 2/7/2022
Revised Release Date: 4/1/2022
Expiration Date: 12/31/2024
The CME credit claim for this activity expires December 31, 2024 at 11:59 PM
Overview: Acute and Chronic Pain Management and Opioid Prescribing for Outpatients covers evidence-based multimodal, multidisciplinary pain management. Topics include pain neurophysiology and chronification, non-opioid and nonpharmacologic pain management, cognitive behavioral therapy, opioid risk assessment, opioid use disorder, opioid and benzodiazepine tapering, and specialty care for pain. A segment on “difficult conversations” shows examples of introducing new treatment plans.
CME: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health, designates this enduring material activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This course has been designated by the A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health for 2.25 credits of education in pain management and the prescription of opioids; and medical ethics/or professional responsibility education.
This CME activity type is an enduring material. Physicians who complete the enduring material may claim the full amount of credit designated for the activity, regardless of the amount of time it took the physicians to complete the activity.
| Faculty: | |
| Alejandro Arroliga, MD, Executive Vice President, Chief Medical Officer | Introduction |
| Emily Garmon, MD, Anesthesiology/Pain Management | Acute Pain |
| Timothy Clark, PhD, Neuropsychology | Neurophysiology & Chronification of Pain |
| Rodney Lange, MD, Anesthesiology/Pain Management | Chronic Pain |
| James Albers, MD, Physical Medicine & Rehabilitation | Non-Opioid Treatment |
| Judy Embry, PhD, Psychology and Timothy Clark, PhD, Neuropsychology | Behavioral Health |
| Yolanda Prevost-Lyon | Patient Testimonial |
| Christopher Burnett, MD, Anesthesiology/Pain Management | Treatment with Opioids |
| Jason Sapp, DO, Psychiatry/Addictionology | Opioid & Benzodiazepine Tapering |
| Amber Whittenburg, MD, Anesthesiology/Pain Management | Specialty Care Interventional Pain Management |
| Jason Sapp, DO, Psychiatry/Addictionology | Specialty Care: Addiction Treatment |
| Timothy Clark, PhD, Neuropsychology | Specialty Care: Interdisciplinary Pain Programs |
Glenn Ledbetter, MD, Internal Medicine | Difficult Conversations |
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS:
The following planners and faculty have disclosed that they have no relevant financial relationships with any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Alejandro Arroliga, MD; Michael Reis, MD; Judy Embry, PhD; Jason Sapp, DO; Christopher Burnett, MD; Amber Whittenburg, MD; Emily Garmon, MD; Rodney Lange, MD; Thomas Glenn Ledbetter, MD; Timothy S Clark, PhD; Yolanda Prevost-Lyon; Cinamon Romers, PhD; Jae Lee Ross, PsyD; James Albers, MD
Method of Participation & Request for CME Credit:
For further study:
www.hhs.gov/sites/default/files/pmtf-final-report-2019-50-23.pdf
-Formulate and carry out evidence-based treatment plans for patients with chronic pain
-Distinguish when opioids are necessary and for how long, prescribing accordingly